Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?
adjuvant chemotherapy
biomarkers
breast cancer
Journal
Cancer management and research
ISSN: 1179-1322
Titre abrégé: Cancer Manag Res
Pays: New Zealand
ID NLM: 101512700
Informations de publication
Date de publication:
2019
2019
Historique:
received:
02
07
2019
accepted:
21
09
2019
entrez:
19
12
2019
pubmed:
19
12
2019
medline:
19
12
2019
Statut:
epublish
Résumé
The decision to administer adjuvant chemotherapy in treatment of early invasive breast cancer (EBC) is often complex, particularly for hormone receptor-positive (HR+) diseases, and current guidelines often classify these patients in an intermediate-risk group. Several biomarkers are currently available in this indication, in order to obtain additional and more accurate prognostic information compared to classic clinicopathological characteristics and guide the indication of adjuvant chemotherapy, optimizing the efficacy/toxicity ratio. We conducted a systematic review to evaluate the clinical validity and clinical utility of five biomarkers (uPA/PAI-1, OncotypeDX
Identifiants
pubmed: 31849525
doi: 10.2147/CMAR.S221676
pii: 221676
pmc: PMC6912012
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
10353-10373Informations de copyright
© 2019 Alexandre et al.
Déclaration de conflit d'intérêts
The authors declared no conflict of interest.
Références
Ann Surg Oncol. 2017 Mar;24(3):669-675
pubmed: 27770345
BMC Genomics. 2006 Oct 30;7:278
pubmed: 17074082
N Engl J Med. 2004 Dec 30;351(27):2817-26
pubmed: 15591335
Bull Cancer. 2015 Sep;102(9):719-29
pubmed: 26235416
PLoS One. 2013;8(3):e58483
pubmed: 23505515
N Engl J Med. 2006 Aug 10;355(6):560-9
pubmed: 16899776
Breast Cancer Res Treat. 2013 Jul;140(2):299-306
pubmed: 23884597
BMC Cancer. 2014 Mar 19;14:211
pubmed: 24645668
Breast J. 2011 Mar-Apr;17(2):172-9
pubmed: 21410584
Clin Breast Cancer. 2008 Apr;8(2):168-77
pubmed: 18621614
Breast Cancer Res Treat. 2012 Apr;132(3):1049-62
pubmed: 22198468
Clin Cancer Res. 2012 Aug 15;18(16):4465-72
pubmed: 22711706
Bull Cancer. 2010 Mar;97(3):341-8
pubmed: 20159676
J Clin Oncol. 2016 Jul 10;34(20):2341-9
pubmed: 26926676
Breast Cancer Res Treat. 2010 Jun;121(3):615-24
pubmed: 20039121
Eur J Cancer. 2013 May;49(8):1825-35
pubmed: 23490655
Lancet. 2012 Feb 4;379(9814):432-44
pubmed: 22152853
J Clin Oncol. 2005 Apr 20;23(12):2716-25
pubmed: 15837986
Nature. 2002 Jan 31;415(6871):530-6
pubmed: 11823860
Cancer Treat Rev. 2008 Apr;34(2):122-36
pubmed: 18162327
PLoS One. 2017 Sep 6;12(9):e0183917
pubmed: 28877230
Lancet. 2009 Dec 19;374(9707):2029-2030
pubmed: 20004965
J Clin Oncol. 2015 Mar 10;33(8):916-22
pubmed: 25332252
Br J Cancer. 2013 Dec 10;109(12):2959-64
pubmed: 24157828
Cancer. 2017 Jan 1;123(1):131-137
pubmed: 27526056
NPJ Breast Cancer. 2019 Aug 2;5:21
pubmed: 31396557
Breast Cancer Res. 2006;8(3):R25
pubmed: 16737553
J Clin Oncol. 2010 Apr 1;28(10):1677-83
pubmed: 20065188
J Clin Oncol. 2006 Aug 10;24(23):3726-34
pubmed: 16720680
Breast Cancer Res Treat. 2016 Feb;156(1):81-9
pubmed: 26909792
Lancet. 2005 May 14-20;365(9472):1687-717
pubmed: 15894097
Nature. 2000 Aug 17;406(6797):747-52
pubmed: 10963602
Nature. 2012 Dec 6;492(7427):59-65
pubmed: 23201678
N Engl J Med. 2016 Aug 25;375(8):717-29
pubmed: 27557300
Eur J Cancer. 1996 Jul;32A(8):1371-81
pubmed: 8869102
Lancet Oncol. 2009 Nov;10(11):1070-6
pubmed: 19801202
Steroids. 2011 Jul;76(8):736-40
pubmed: 21447351
J Clin Oncol. 2010 Apr 10;28(11):1829-34
pubmed: 20212256
J Natl Cancer Inst. 2009 Nov 4;101(21):1446-52
pubmed: 19815849
N Engl J Med. 2018 Jul 12;379(2):111-121
pubmed: 29860917
Int J Cancer. 2007 Mar 1;120(5):1070-5
pubmed: 17131339
Breast Cancer Res. 2014 Apr 12;16(2):R38
pubmed: 24725534
N Engl J Med. 2015 Nov 19;373(21):2005-14
pubmed: 26412349
Ann Oncol. 2011 Aug;22(8):1736-47
pubmed: 21709140
J Clin Pathol. 2010 Jun;63(6):513-7
pubmed: 20498025
J Clin Oncol. 2009 Mar 10;27(8):1160-7
pubmed: 19204204
J Clin Oncol. 2016 Apr 1;34(10):1134-50
pubmed: 26858339
Oncologist. 2006 Sep;11(8):868-77
pubmed: 16951390
BMC Cancer. 2012 Oct 05;12:456
pubmed: 23039280
Lancet Oncol. 2013 Oct;14(11):1067-1076
pubmed: 24035531
BMC Med Genomics. 2015 Aug 22;8:54
pubmed: 26297356
Clin Breast Cancer. 2015 Dec;15(6):458-66
pubmed: 26233757
Breast Dis. 2016 Jul 28;36(2-3):65-71
pubmed: 27662272
Breast Cancer Res Treat. 2009 Oct;117(3):483-95
pubmed: 18819002
J Natl Cancer Inst. 2017 Jan 25;109(4):
pubmed: 28122895
Anticancer Res. 2009 May;29(5):1475-82
pubmed: 19443353
Cancer Lett. 2014 Dec 1;355(1):70-5
pubmed: 25218596
Cancer. 1988 Aug 1;62(3):531-3
pubmed: 3134120
Genet Med. 2009 Jan;11(1):3-14
pubmed: 18813139
Clin Cancer Res. 2016 Feb 1;22(3):560-6
pubmed: 26152740
J Natl Cancer Inst. 2014 Sep 24;106(11):null
pubmed: 25255803
J Mol Diagn. 2014 Mar;16(2):190-7
pubmed: 24378251
Clin Chem. 2007 Jun;53(6):1084-91
pubmed: 17463177
Breast Cancer Res Treat. 2010 Feb;119(3):551-8
pubmed: 19214742
J Clin Oncol. 2013 Aug 1;31(22):2783-90
pubmed: 23816962
Clin Cancer Res. 2010 Nov 1;16(21):5222-32
pubmed: 20837693
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
pubmed: 11553815
Virchows Arch. 2012 Mar;460(3):251-9
pubmed: 22371223
Cancer Res. 2002 Aug 15;62(16):4617-22
pubmed: 12183417
BMC Cancer. 2016 Jul 28;16:555
pubmed: 27469239
J Natl Cancer Inst. 2002 Jan 16;94(2):116-28
pubmed: 11792750
J Natl Cancer Inst. 2001 Jun 20;93(12):913-20
pubmed: 11416112
N Engl J Med. 2019 Jun 20;380(25):2395-2405
pubmed: 31157962
J Cancer Res Clin Oncol. 2010 Jun;136(6):939-44
pubmed: 19946706
Cancer. 2017 Jul 1;123(13):2422-2431
pubmed: 28199747
Ann Oncol. 2012 Nov;23(11):2866-73
pubmed: 22532584
Breast. 2012 Dec;21(6):769-78
pubmed: 22738860
Ann Oncol. 2012 Dec;23(12):2997-3006
pubmed: 23166150
J Clin Oncol. 2017 Aug 20;35(24):2838-2847
pubmed: 28692382
J Clin Oncol. 2008 Sep 1;26(25):4063-71
pubmed: 18678838
Ann Oncol. 2014 Feb;25(2):339-45
pubmed: 24347518
J Natl Cancer Inst. 2016 Apr 29;108(9):
pubmed: 27130929
Br J Cancer. 2012 Aug 21;107(5):800-7
pubmed: 22850554
J Natl Cancer Inst. 2006 Sep 6;98(17):1183-92
pubmed: 16954471
Semin Thromb Hemost. 1991 Jul;17(3):303-12
pubmed: 1796300
Breast Cancer Res Treat. 2008 Mar;108(2):233-40
pubmed: 17468949
Clin Cancer Res. 2014 Mar 1;20(5):1298-305
pubmed: 24520097
J Clin Oncol. 2016 Jul 10;34(20):2350-8
pubmed: 27217450
Adv Ther. 2015 Dec;32(12):1237-47
pubmed: 26610383
N Engl J Med. 2002 Dec 19;347(25):1999-2009
pubmed: 12490681
Breast Cancer Res Treat. 2017 Oct;165(3):611-621
pubmed: 28685212
Breast. 2013 Oct;22(5):682-90
pubmed: 23347730
BMC Cancer. 2011 Apr 16;11:140
pubmed: 21496284
J Natl Cancer Inst. 1996 Oct 16;88(20):1456-66
pubmed: 8841020
Lancet Oncol. 2010 Jan;11(1):55-65
pubmed: 20005174
J Natl Cancer Inst. 2013 Oct 2;105(19):1504-11
pubmed: 24029245
PLoS One. 2009 Jun 15;4(6):e5911
pubmed: 19547727
J Clin Oncol. 2008 Feb 10;26(5):721-8
pubmed: 18258979
Br J Cancer. 2015 Apr 14;112(8):1405-10
pubmed: 25867274
Breast Cancer Res Treat. 2014 Feb;143(3):587-92
pubmed: 24445566
Ann Oncol. 2013 Mar;24(3):640-7
pubmed: 23035151
Ann Oncol. 2010 Apr;21(4):717-22
pubmed: 19825882
Cancer. 2010 Jul 1;116(13):3112-8
pubmed: 20564629
Breast Cancer Res Treat. 2009 Jul;116(2):295-302
pubmed: 18661261
Clin Cancer Res. 2011 Sep 15;17(18):6012-20
pubmed: 21807638
J Natl Cancer Inst. 2016 Jul 10;108(11):
pubmed: 27400969